Currently, no cure for DMD is available, however novel therapeutic strategies to restore dystrophin function are emerging, some with promising results in clinical trials [21,22,23] in which reliable biomarkers and surrogate endpoints of the disease are crucial to evaluate treatment efficacy [24,25]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.